Lantheus Grants Allegheny Health Network Exclusive Rights for the Use of its Microbubbles in Combination with Ultrasound Assisted Gene Therapy for the Development of a Proposed Treatment for Xerostomi
Go back to Lantheus Grants Allegheny Health Network Exclusive Rights for the Use of its Microbubbles in Combination with Ultrasound Assisted Gene Therapy for the Development of a Proposed Treatment for Xerostomi| (NASDAQ: LNTH) | Delayed: 106.20 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $106.20 | 52 Week High | $10.70 | |||
| Open | $106.20 | 52 Week Low | $1.76 | |||
| Day High | $106.20 | P/E | N/A | |||
| Day Low | $106.20 | EPS | $0.00 | |||
| Volume | 661 | |||||
